摘要
Intervertebral disc degeneration (IDD) is a common orthopedic multifactorial disease associated with spine related disorders, such as low back pain. Recent studies have shown that both platelet-rich plasma (PRP) and exosomes could be used to treat IDD, but the effects and mechanism of PRP-derived exosomes in the treatment of IDD are still unclear. This study showed that PRP-derived exosomes inhibited the polarization of M1 macrophages by regulating the NF-kappa B and MAPK pathways and affected the polarization of M2 macrophages by regulating STAT6 phosphorylation. Additionally, PRP-derived exosomes promoted the autophagic degradation of NLRP3 by increasing NLRP3 ubiquitination and reducing IL-1 beta and Caspase-1 production. Moreover, PRP derived exosomes could reduce IL-1 beta -induced apoptosis of nucleus pulposus cells. Lastly, in vivo experiments confirmed that PRP-derived exosomes reduced the expression of inflammatory mediators and apoptotic factors, which could thereby alleviate the progression of IDD. Taken together, these data showed that PRP-derived exosomes could alleviate the IDD-associated inflammation by regulating the ubiquitination and autophagic degradation of NLRP3 inflammasome, providing new insights into the treatment of IDD.
学科与关键词
- Pure platelet-rich plasma promotes semaphorin-3A expression: a novel insight to ameliorate intervertebral disk degeneration in vitroHuang, Jie; Lian, Shi-lin; Han, Jia-heng; Lu, Zheng-cao; Ding, Yu*Journal of Orthopaedic Surgery and Research, 2023, 18(1): 789.
- Mesenchymal stem cell exosomes inhibit nucleus pulposus cell apoptosis via the miR-125b-5p/TRAF6/NF-κB pathway axisDuan, Yang; Yu, Cheng; Kuang, Wenhao; Li, Jianjun; Qiu, Sujun; Ni, Songjia; Chen, Zhong*ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 55(12): 1938-1949.被引 1
- Kindlin-2 inhibits Nlrp3 inflammasome activation in nucleus pulposus to maintain homeostasis of the intervertebral discChen, Sheng; Wu, Xiaohao; Lai, Yumei; Chen, Di; Bai, Xiaochun; Liu, Sheng; Wu, Yongchao; Chen, Mingjue; Lai, Yuxiao; Cao, Huiling*; Shao, Zengwu*; Xiao, Guozhi*Bone Research, 2022, 10(1): 5.被引 43
